Segment Reporting - Additional Information (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) segment	Dec. 31, 2021 USD ($)	Dec. 31, 2020
Segment Reporting Information [Line Items]
Number of operating business segment | segment	1
Property, plant and equipment, net	$ 32,451	$ 60,510
United States
Segment Reporting Information [Line Items]
Property, plant and equipment, net		$ 56,100
Revenue | UCB | Customer Concentration Risk
Segment Reporting Information [Line Items]
Percentage revenue from customers	37.00%	36.00%	23.00%
Revenue | Baxalta Incorporated Or Takeda P L C | Customer Concentration Risk
Segment Reporting Information [Line Items]
Percentage revenue from customers	25.00%	23.00%	14.00%
Revenue | Astra Zeneca Ab | Customer Concentration Risk
Segment Reporting Information [Line Items]
Percentage revenue from customers	14.00%	16.00%	13.00%
Revenue | Pfizer | Customer Concentration Risk
Segment Reporting Information [Line Items]
Percentage revenue from customers	11.00%	13.00%
Revenue | BMS | Customer Concentration Risk
Segment Reporting Information [Line Items]
Percentage revenue from customers			33.00%
Property, Plant and Equipment | Geographic Concentration Risk | United States
Segment Reporting Information [Line Items]
Percentage revenue from customers		93.00%